{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T03:17:53Z","timestamp":1780975073176,"version":"3.54.1"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>A 55-year-old woman with recurrent ovarian clear cell carcinoma who underwent complete surgical staging and completed chemotherapy session approximately 7 months before. She presented with increased CA-125 levels. <jats:sup>68<\/jats:sup>Ga-FAPI-46 PET showed significantly higher tumor-to-background contrast of recurrent intra-abdominal node metastases and distant metastases, which were undetectable in the <jats:sup>18<\/jats:sup>F-FDG PET. These findings changed the patient management. Larger studies with comparisons with other imaging modalities are required to validate the diagnostic performance.<\/jats:p>","DOI":"10.1097\/rlu.0000000000003975","type":"journal-article","created":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T16:08:54Z","timestamp":1641830934000},"page":"e210-e212","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":15,"title":["Intense 68Ga-FAPI-46 Activity in Lesions of Recurrent Ovarian Clear Cell Carcinoma That Were Negative on FDG PET\/CT Study"],"prefix":"10.1097","volume":"47","author":[{"given":"Dheeratama","family":"Siripongsatian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chetsadaporn","family":"Promteangtrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anchisa","family":"Kunawudhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peerapon","family":"Kiatkittikul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanisa","family":"Chotipanich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1097\/IGC.0000000000000180","article-title":"Maximum standardized uptake value of fluorodeoxyglucose positron emission tomography\/computed tomography is a prognostic factor in ovarian clear cell adenocarcinoma","volume":"24","year":"2014","journal-title":"Int J Gynecol Cancer"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/IGC.0000000000000074","article-title":"Diagnostic value of preoperative SUVmax on FDG-PET\/CT for the detection of ovarian cancer","volume":"24","year":"2014","journal-title":"Int J Gynecol Cancer"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.3892\/or.2017.5398","article-title":"Low uptake of fluorodeoxyglucose in positron emission tomography\/computed tomography in ovarian clear cell carcinoma may reflect glutaminolysis of its cancer stem cell-like properties","volume":"37","year":"2017","journal-title":"Oncol Rep"},{"key":"bib4-20250621","first-page":"1551","article-title":"Evaluation of CA125, physical and radiological findings in follow-up of ovarian cancer patients","volume":"25","year":"2005","journal-title":"Anticancer Res"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"9338","DOI":"10.1200\/JCO.2005.02.2582","article-title":"Risk of epithelial ovarian cancer recurrence in patients with rising serum CA-125 levels within the normal range","volume":"23","year":"2005","journal-title":"Am J Clin Oncol"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"176","DOI":"10.4103\/wjnm.WJNM_31_17","article-title":"Systematic review on the accuracy of positron emission tomography\/computed tomography and positron emission tomography\/magnetic resonance imaging in the management of ovarian cancer: is functional information really needed?","volume":"16","year":"2017","journal-title":"World J Nucl Med"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2967\/jnumed.119.227967","article-title":"68Ga-FAPI PET\/CT: tracer uptake in 28 different kinds of cancer","volume":"60","year":"2019","journal-title":"J Nucl Med"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.1007\/s00259-021-05378-0","article-title":"68Ga-FAPI-PET\/CT in patients with various gynecological malignancies","volume":"48","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003975","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T20:07:23Z","timestamp":1750536443000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003975"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":8,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000003975","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]}}}